Mdxhealth SA (NASDAQ:MDXH) (the "Company" or "mdxhealth"), a leader in urology-focus

IRVINE, California – July 2, 2026 (GlobeNewswire) – Mdxhealth SA (NASDAQ: MDXH) (the "Company" or "m

The publication represents the first major peer-reviewed milestone from the Oxford collaboration and

Mdxhealth Announces Peer-Reviewed Publication of Oxford GPS-ProMPT Study in European Urology Oncolog

Lake Street analyst Thomas Flaten maintains MDxHealth (NASDAQ:MDXH) with a Buy and lowers the pri

TD Cowen analyst Dan Brennan maintains MDxHealth (NASDAQ:MDXH) with a Buy and lowers the price ta

US stocks up, Dow gains 250+ pts. Tech sector up 0.8%, healthcare down 0.3%. Retail sales rise 0.5%

Analyst ratings for top names changed: Doximity cut to neutral, National Vision lowered price target

BTIG analyst Mark Massaro maintains MDxHealth (NASDAQ:MDXH) with a Buy and lowers the price targe

Cisco Inc (NASDAQ: CSCO) beat expectations and raised guidance with $15.84B revenue and $1.06 EPS. S

MDxHealth NASDAQ: MDXH reported first-quarter 2026 revenue of $27.4 million while announcing a strat

MDxHealth SA (MDXH) Q1 2026 Earnings Call Transcript

MDxHealth (NASDAQ:MDXH) lowers FY2026 sales outlook from $137.000 million-$140.000 million to $110.0

MDxHealth (NASDAQ:MDXH) reported quarterly losses of $(0.17) per share which missed the analyst cons

Mdxhealth Reports Q1-2026 Results Conference call with Q&A today at 4:30 PM ET / 22:30 CET IRVINE, C

Mdxhealth SA (NASDAQ: MDXH), a leading precision diagnostics company, today announced it will releas

MDxHealth SA (NASDAQ: MDXH - Get Free Report) has earned a consensus rating of "Moderate Buy" from t

MDxHealth (NASDAQ: MDXH - Get Free Report) and Health Catalyst (NASDAQ: HCAT - Get Free Report) are

Mdxhealth Highlights Data from Oxford's ProMPT Study Demonstrating the Genomic Prostate Score GPS Te

MDxHealth SA (MDXH) Q4 2025 Earnings Call Transcript

MDxHealth (NASDAQ:MDXH) affirms FY2026 sales outlook from $137.000 million-$140.000 million to $137.

MDxHealth (NASDAQ:MDXH) reported quarterly losses of $(0.17) per share which missed the analyst cons

Mdxhealth to Present Fourth Quarter and Full Year 2025 Financial Results and Corporate Update on Feb

MDxHealth Reports Preliminary Fourth Quarter and Full Year 2025 Revenues, Issues 2026 Revenue Guidan

Mdxhealth and University of Oxford to validate GPS test in largest randomized trial of treatment eff

Shares of MDxHealth SA (NASDAQ: MDXH - Get Free Report) have been assigned an average rating of "Mod

Shares of MDxHealth SA (NASDAQ: MDXH - Get Free Report) have received a consensus rating of "Moderat

MDxHealth SA ( MDXH ) Q3 2025 Earnings Call November 12, 2025 4:30 PM EST Company Participants Micha

If you are looking for stocks that are well positioned to maintain their recent uptrend, MDxHealth S

Appointment of Executive Chairman, proposed change of name and strategy update Company to pursue rev

MDxHealth SA (MDXH) came out with a quarterly loss of $0.15 per share versus the Zacks Consensus Est

M dxh ealth Reports Preliminary Second Quarter 202 5 Results , Reaches Positive Adjusted EBITDA , an

  On Tuesday, 647 companies set new 52-week lows.